The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris
Clinical trial NCT01768013 · COMPLETED
Trial details
- NCT number
- NCT01768013
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2012-10-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.